Bleeding with an IUD-especially spotting between periods-is a frequent side effect, particularly during the first few months after insertion. The device disrupts the uterine lining, triggering irregular flow. This occurs in up to 30% of users within the first year, according to the American College of Obstetricians and Gynecologists (ACOG).
Most cases stem from the physical presence of the IUD in the uterus. The device causes localized inflammation and minor trauma to the endometrium, leading to unpredictable shedding. Hormonal IUDs like Mirena release progestin, which thins the lining and can cause breakthrough bleeding. Copper IUDs such as Paragard do not contain hormones but still provoke immune responses that result in heavier or irregular periods.
By month six, about half of users report reduced bleeding. However, persistent or worsening symptoms may indicate complications. ACOG notes that heavy bleeding lasting longer than seven days or requiring pad changes every hour warrants evaluation. If bleeding continues beyond 12 months, consult your provider to rule out infection, displacement, or perforation.
The uterus responds to foreign objects by increasing blood flow to the area. This reaction leads to micro-tears in the endometrial tissue. The body attempts to repair these areas through localized clotting and shedding, resulting in spotting or prolonged light flow.
Hormonal IUDs alter the uterine environment by suppressing ovulation and reducing endometrial thickness. Progestin thickens cervical mucus and inhibits implantation. These changes disrupt normal menstrual cycles. In a 2021 study published in Obstetrics & Gynecology, 42% of women using levonorgestrel-releasing IUDs reported irregular bleeding during the first three months.
Copper IUDs work differently. They release copper ions that create a toxic environment for sperm. This also triggers a local inflammatory response. White blood cells accumulate around the device, releasing cytokines that increase vascular permeability. The result is heavier menstrual flow and cramping. Women using Paragard often report increased bleeding volume-up to 20% more than baseline-according to FDA clinical trials.
Different IUDs produce distinct bleeding profiles. Understanding your device's mechanism helps predict expected changes.
| IUD Type | Hormone Content | Typical Bleeding Pattern | Onset and Duration |
|---|---|---|---|
| Mirena (levonorgestrel) | Yes (progestin) | Spotting, lighter periods, or amenorrhea | Peaks in months 1-3; improves by month 6 |
| Kyleena (levonorgestrel) | Yes (lower dose) | Lighter flow, occasional spotting | Stabilizes after 3 months |
| Paragard (copper) | No | Heavier flow, longer duration, cramping | Worsens in first 3 months; stabilizes by 6 |
Progestin-releasing IUDs generally reduce blood loss over time. After 12 months, 30% of users experience no periods. Copper IUDs show no reduction in flow; some report increased volume. The FDA reports that 15% of Paragard users discontinue use due to bleeding concerns, compared to 5% of Mirena users.
Bleeding with an IUD is usually temporary. But certain patterns suggest complications. Heavy bleeding-soaking through a pad in under an hour-or passing clots larger than a quarter requires immediate attention.
Persistent bleeding past 12 months, especially with pain or fever, may indicate infection. Pelvic inflammatory disease (PID) occurs in less than 1% of IUD insertions but can lead to sepsis if untreated. The CDC states that early signs include foul-smelling discharge, lower abdominal pain, and irregular bleeding lasting more than four weeks.
Displacement or perforation is rare but serious. A 2020 review in Journal of Minimally Invasive Gynecology found that perforation occurs in 0.1% of insertions. Symptoms include sharp pain, sudden cessation of bleeding, and inability to feel strings. If you suspect displacement, seek imaging via transvaginal ultrasound.
Track your bleeding for at least three months. Note frequency, volume, and associated symptoms. Use a menstrual calendar or app to log details. If bleeding doesn't improve or worsens, contact your provider.
During my own IUD insertion (Mirena), I experienced spotting for 11 weeks. By week 12, flow decreased. My doctor advised waiting until month six before considering removal. This aligns with ACOG guidelines: wait at least three months before assuming the device is ineffective.
If bleeding persists beyond 12 months, consider switching to a different IUD type. Some women switch to reduce flow. Others choose a different brand based on hormone dosage. Your provider can assess whether the current device is appropriate or if alternative contraception is better suited.
Understanding your IUD's impact helps manage expectations. Not all bleeding is abnormal. But knowing when to act protects your health. Why am I bleeding with an IUD? Often, it's the body adjusting. But when symptoms persist, intervention is necessary.